Suchergebnisse

59 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: Cisplatin, シスプラチン

• 2024, Rana JN, Mumtaz S, Han I, Ha Choi E
  Harnessing the synergy of nanosecond high-power microwave pulses and cisplatin to increase the induction of apoptosis in cancer cells through the activation of ATR/ATM and intrinsic pathways [med./bio.]
  Free Radic Biol Med 225: 221-235
• 2024, Woo SH, Jung BC, Kim JY, Lee YH, Kim YS
  PEMF Potentiates Doxorubicin-induced Late G2 Arrest in MDA-MB-231 Breast Cancer Cells [med./bio.]
  Anticancer Res 44 (7): 2837-2846
• 2024, Zafari J, Rastegar-Pouyani N, Javani Jouni F, Najjar N, Azarshin SZ, Jafarzadeh E, Abdolmaleki P, Hoseini Shirazi F
  Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines [med./bio.]
  Sci Rep 14: 5792
• 2023, Abdelrahman SA, Raafat N, Abdelaal GMM, Aal SMA
  Electric field-directed migration of mesenchymal stem cells enhances their therapeutic potential on cisplatin-induced acute nephrotoxicity in rats [med./bio.]
  Naunyn Schmiedebergs Arch Pharmacol 396 (6): 1077-1093
• 2022, Yu X, Ji X, Fan Y, Yu B, Wang X, Feng C, Zhang L, Song C, Zhang X
  Static Magnetic Fields Protect against Cisplatin-Induced Kidney Toxicity [med./bio.]
  Antioxidants 12 (1): 73
• 2022, Wolff CM, Bekeschus S
  Synergistic In Vitro Anticancer Toxicity of Pulsed Electric Fields and Glutathione [med./bio.]
  Int J Mol Sci 23 (23): 14772
• 2022, Tayebi-khorami M, Chegeni N, Tahmasbi Birgani M, Danyaei A, Fardid R, Zafari J
  Enhancement of Cisplatin Sensitivity by Microwave Radiation in Ovarian Cancer Cells [med./bio.]
  Pharm Sci 28 (2): 295-303
• 2022, Chen MY, Li J, Zhang N, Waldorff EI, Ryaby JT, Fedor P, Jia Y, Wang Y
  In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells [med./bio.]
  Technol Cancer Res Treat 21: 15330338221124658
• 2022, Shibaki R, Kakikawa M
  Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5 [med./bio.]
  Electromagn Biol Med 41 (3): 343-351
• 2022, Wang S, Huyan T, Lou C, Shang P, Zhang H
  12 T high static magnetic field suppresses osteosarcoma cells proliferation by regulating intracellular ROS and iron status [med./bio.]
  Exp Cell Res 417 (2): 113223
• 2021, Mumblat H, Martinez-Conde A, Braten O, Munster M, Dor-On E, Schneiderman RS, Porat Y, Voloshin T, Davidi S, Blatt R, Shteingauz A, Tempel-Brami C, Zeevi E, Lajterer C, Shmueli Y, Danilov S, Haber A, Giladi M, Weinberg U, Kinzel A, Palti Y
  Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models [med./bio.]
  Lung Cancer 160: 99-110
• 2020, Rageh MM, El-Garhy MR, Mohamad EA
  Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity [med. Anw.]
  Naunyn Schmiedebergs Arch Pharmacol 393 (8): 1475-1485
• 2020, Karanam NK, Ding L, Aroumougame A, Story MD
  Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy [med./bio.]
  Transl Res 217: 33-46
• 2019, Rageh MM, Mohamad EA, El-Garhy MR
  Magnetic Field Improves the Efficiency of Low Dose Cis-Platin by Alteration the Oxidative Stress in Ehrlich Carcinoma-Bearing Mice [med./bio.]
  Egypt Acad J Biol Sci B Zool 11 (3): 107-112
• 2019, Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, Mencoboni M, Planchard D, Chella A, Crinò L, Krzakowski M, Rüssel J, Maconi A, Gianoncelli L, Grosso F
  Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial [med. Anw.]
  Lancet Oncol 20 (12): 1702-1709
• 2019, Michel O, Błasiak P, Saczko J, Kulbacka J, Drąg-Zalesińska M, Rzechonek A
  Electropermeabilization of metastatic chondrosarcoma cells from primary cell culture [med./bio.]
  Biotechnol Appl Biochem 66 (6): 945-954
• 2019, Jalali A, Zafari J, Jouni FJ, Abdolmaleki P, Shirazi FH, Khodayar MJ
  Combination of static magnetic field and cisplatin in order to reduce drug resistance in cancer cell lines [med./bio.]
  Int J Radiat Biol 95 (8): 1194-1201
• 2019, Kakikawa M, Maeda T, Yamada S
  Combined Effect of 60 Hz Magnetic Fields and Anticancer Drugs on Human Hepatoma HepG2 Cells [med./bio.]
  IEEE J Electromagn RF Microw Med Biol 3 (1): 56 - 60
• 2018, Le Renard PE, Nimmervoll B, Fellner F, Oppelt P
  Cisplatin in-vitro activity with co-exposure to MRI [med./bio.]
  2018 EMF-Med 1st World Conference on Biomedical Applications of Electromagnetic Fields (EMF-Med), Split, Croatia. IEEE: S. 1-2; ISBN 978-1-5386-5922-9
• 2018, Sanie-Jahromi F, Saadat M
  Effects of electromagnetic field, cisplatin and morphine on cytotoxicity and expression levels of DNA repair genes [med./bio.]
  Mol Biol Rep 45 (5): 807-814
• 2018, Yuan LQ, Wang C, Zhu K, Li HM, Gu WZ, Zhou DM, Lai JQ, Zhou D, Lv Y, Tofani S, Chen X
  The antitumor effect of static and extremely low frequency magnetic fields against nephroblastoma and neuroblastoma [med./bio.]
  Bioelectromagnetics 39 (5): 375-385
• 2018, Mahmoudinasab H, Saadat M
  Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells [med./bio.]
  DNA Cell Biol 37 (4): 330-335
• 2018, Ryu J, Lee K, Joe C, Joo J, Lee N, Yoo HS
  Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report [med. Anw.]
  Integr Cancer Ther 17 (2): 558-561
• 2017, Kamalipooya S, Abdolmaleki P, Salemi Z, Javani Jouni F, Zafari J, Soleimani H
  Simultaneous application of cisplatin and static magnetic field enhances oxidative stress in HeLa cell line [med./bio.]
  In Vitro Cell Dev Biol Anim 53 (9): 783-790
• 2017, Sanie-Jahromi F, Saadat M
  Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin [med./bio.]
  Biomed Pharmacother 94: 564-568
• 2016, Luo Y, Ji X, Liu J, Li Z, Wang W, Chen W, Wang J, Liu Q, Zhang X
  Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol [med./bio.]
  Bioelectrochemistry 109: 31-40
• 2016, Sanie-Jahromi F, Saadat I, Saadat M
  [Details] Effects of extremely low frequency electromagnetic field and cisplatin on mRNA levels of some DNA repair genes [med./bio.]
  Life Sci 166: 41-45
• 2016, Yin S, Chen X, Xie H, Zhou L, Guo D, Xu Y, Wu L, Zheng S
  Nanosecond pulsed electric field (nsPEF) enhance cytotoxicity of cisplatin to hepatocellular cells by microdomain disruption on plasma membrane [med./bio.]
  Exp Cell Res 346 (2): 233-240
• 2016, Kranjc S, Kranjc M, Scancar J, Jelenc J, Sersa G, Miklavcic D
  Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo [med./bio.]
  Radiol Oncol 50 (1): 39-48
• 2016, Baharara J, Hosseini N, Farzin TR
  [Details] Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation [med./bio.]
  Cytotechnology 68 (4): 1403-1413
• 2015, Xu L, Guo W, Liu Y, Zhang X, Yu J, Wu W, Zhao T
  [Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells] [fremdsprachig]
  Sheng Wu Gong Cheng Xue Bao 31 (9): 1363-1374
• 2014, Vergallo C, Ahmadi M, Mobasheri H, Dini L
  Impact of Inhomogeneous Static Magnetic Field (31.7-232.0 mT) Exposure on Human Neuroblastoma SH-SY5Y Cells during Cisplatin Administration [med./bio.]
  PLoS One 9 (11): e113530
• 2014, Kakikawa M, Imai S, Yamada S
  [Details] Effect of Extremely Low-Frequency (ELF) Magnetic Fields on the Potency of Drugs in Bacterial Cells [med./bio.]
  IEEE Trans Magn 50 (4): 1-4
• 2014, Giladi M, Weinberg U, Schneiderman RS, Porat Y, Munster M, Voloshin T, Blatt R, Cahal S, Itzhaki A, Onn A, Kirson ED, Palti Y
  Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo [med./bio.]
  Semin Oncol 41: S35-S41
• 2014, Zhang K, Chen W, Bu T, Qi H, Sun R, He X
  Decreased P-glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells [med./bio.]
  Bioelectromagnetics 35 (6): 437-443
• 2014, Zhao C, Chen J, Yu B, Chen X
  Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy [med. Anw.]
  Int J Radiat Biol 90 (10): 853-858
• 2013, El-Bialy NS, Rageh MM
  Extremely Low-Frequency Magnetic Field Enhances the Therapeutic Efficacy of Low-Dose Cisplatin in the Treatment of Ehrlich Carcinoma [med./bio.]
  Biomed Res Int: 189352
• 2012, Kakikawa M, Yamada S
  [Details] Effect of Extremely Low-Frequency (ELF) Magnetic Fields on Anticancer Drugs Potency [med./bio.]
  IEEE Trans Magn 48 (11): 2869-2872
• 2012, Yeganyan LR, Muradyan RE, Arsenyan FH, Bazikyan GK, Ayrapetyan SN
  Magnetically treated water at 4 Hz and 2.5 mT as a modulator of cisplatin effect on cell hydration and ouabain binding of sarcoma-180 tissue [med./bio.]
  Environmentalist 32 (2): 236-241
• 2012, Buldak RJ, Polaniak R, Buldak L, Zwirska-Korczala K, Skonieczna M, Monsiol A, Kukla M, Dulawa-Buldak A, Birkner E
  [Details] Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells [med./bio.]
  Bioelectromagnetics 33 (8): 641-651
• 2012, Breton M, Mir LM
  [Details] Microsecond and nanosecond electric pulses in cancer treatments [Review]
  Bioelectromagnetics 33 (2): 106-123
• 2011, Liu Y, Qi H, Sun RG, Chen WF
  An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes [med./bio.]
  Tumori 97 (3): 386-392
• 2011, Luo P, Cao P, Yao Z
  [Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in Treatment of Malignant Pericardial Effusion Caused by Lung Cancer] [fremdsprachig]
  Zhongguo Fei Ai Za Zhi 14 (7): 593-597
• 2011, Jia D, Rao W, Wang C, Jin C, Wang S, Chen D, Zhang M, Guo J, Chang Z, Liu J
  Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia [med. Anw.]
  Int J Hyperthermia 27 (3): 275-285
• 2011, Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ
  The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study [med. Anw.]
  Int J Hyperthermia 27 (1): 27-32
• 2010, Chen WF, Qi H, Sun RG, Liu Y, Zhang K, Liu JQ
  Static magnetic fields enhanced the potency of cisplatin on k562 cells [med./bio.]
  Cancer Biother Radiopharm 25 (4): 401-408
• 2010, Huilgol NG, Gupta S, Dixit R
  Chemoradiation with hyperthermia in the treatment of head and neck cancer [med. Anw.]
  Int J Hyperthermia 26 (1): 21-25
• 2008, Ruiz-Gomez MJ, Merino-Moyano MD, Cebrian-Martin MG, Prieto-Barcia MI, Martinez-Morillo M
  [Details] No effect of 50 Hz 2.45 mT magnetic field on the potency of cisplatin, mitomycin C, and methotrexate in S. cerevisiae [med./bio.]
  Electromagn Biol Med 27 (3): 289-297
• 2007, Mochiki E, Shioya M, Sakurai H, Andoh H, Ohno T, Aihara R, Asao T, Kuwano H
  Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding [med. Anw.]
  Int J Hyperthermia 23 (6): 493-500
• 2005, Zhang S, Xu G, Liu C, Xiao S, Sun Y, Su X, Cai Y, Li D, Xu B
  Clinical study of recombinant adenovirus-p53 (Adp53) combined with hyperthermia in advanced cancer (a report of 15 cases) [med. Anw.]
  Int J Hyperthermia 21 (7): 631-636